Detailed cell-and-protein maps of the brain in Alzheimer's

Core C: Spatial Multiomics Core

NIH-funded research Columbia University Health Sciences · NIH-11180244

Creating high-resolution maps of brain cells and proteins in people with and without Alzheimer's to link age, protein clumps, and blood vessel changes to altered cell patterns and gene activity.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11180244 on NIH RePORTER

What this research studies

This core develops standardized lab and imaging workflows that map where specific genes and proteins sit inside human brain tissue at single-cell resolution. It works mainly with donated postmortem brain samples from people with Alzheimer's and age-matched controls and generates spatial transcriptomics and multiplexed proteomics data. The Core coordinates with biospecimen and computational teams to produce, quality-control, and integrate large-scale datasets for multiple linked research projects. The goal is to make reproducible, shareable maps that researchers can use to study how risk factors change brain tissue organization.

Who could benefit from this research

Good fit: Ideal candidates are people with Alzheimer's disease (and age-matched controls) who are willing to join a brain donation program or have their postmortem tissue shared through affiliated brain banks.

Not a fit: People expecting immediate personal treatment benefits or those with unrelated neurological conditions are unlikely to receive direct clinical benefit from this core's work in the short term.

Why it matters

Potential benefit: If successful, this work could reveal new biological signatures and targets that help diagnose, monitor, or treat Alzheimer's disease earlier and more precisely.

How similar studies have performed: Smaller-scale spatial transcriptomics and multiplex proteomics studies in human brain tissue have produced promising findings, but this large, standardized core approach is relatively new.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease pathology
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.